| Application |
Clinically, mouse monoclonal antibodies (IgG) and their fragments are used for in-vivo diagnostic procedures (radionuclides) and as treatment for patients with various diseases. In patients, even a single dose injection of murine monoclonal IgG may induce immune response directed against this foreign protein (immunogen). In the circulation, human antibody against murine IgG could bind to the injected murine IgG and, therefore, diminish the efficacy of either the application of the in-vivo diagnosis or treatment. Especially, the HAMA would increase the risk of anaphylactic complications to subsequent administration of the murine IgG based therapy. |